Hepatocyte growth factor, its receptor, and their potential value in cancer therapies

被引：219
|
作者：
Jiang, WG
Martin, TA
Parr, C
Davies, G
Matsumoto, K
Nakamura, T
机构：
[1] Cardiff Univ, Walles Coll Med, Dept Surg, Metastasis & Angiogenesis Res Grp, Cardiff CF14 4XN, S Glam, Wales
[2] Osaka Univ, Grad Sch Med, Div Mol Regenerat Med, Course Adv Med, Suita, Osaka, Japan
来源：
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 2005年 / 53卷 / 01期
关键词：
hepatocyte growth factor; HGF; cMET; cancer metastasis; angiogenesis; signal transduction; cancer therapies;
D O I：
10.1016/j.critrevonc.2004.09.004
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Hepatocyte growth factor plays multiple roles in cancer, by acting as a motility and invasion stimulating factor, promoting metastasis and tumour growth. Furthermore, it acts as a powerful angiogenic factor. The pivotal role of this factor in cancer has indicated HGF as being a potential target in cancer therapies. The past few years have seen rapid progress in developing tools in targeting HGF, in the context of cancer therapies, including development of antagonists, small compounds, antibodies and genetic approaches. The current article discusses the potential value of HGF and its receptor as targets in cancer therapies, the current development in anti-HGF research, and the clinical value of HGF in prognosis and treatment. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：35 / 69
页数：35
相关论文
共 50 条
  • [21] Inhibitors targeting hepatocyte growth factor receptor and their potential therapeutic applications
    Cui, Jingrong Jean
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2007, 17 (09) : 1035 - 1045
  • [22] Independent prognostic value of serum hepatocyte growth factor in bladder cancer
    Gohji, K
    Nomi, M
    Niitani, Y
    Kitazawa, S
    Fujii, A
    Katsuoka, Y
    Nakajima, M
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) : 2963 - 2971
  • [23] Prognostic Value of Hepatocyte Growth Factor Receptor Expression in Patients with Perihilar Cholangiocarcinoma
    Watanabe, Hiroyuki
    Yokoyama, Yukihiro
    Kokuryo, Toshio
    Ebata, Tomoki
    Igami, Tsuyoshi
    Sugawara, Gen
    Mizuno, Takashi
    Shimoyama, Yoshie
    Nagino, Masato
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (07) : 2235 - 2242
  • [24] Prognostic Value of Hepatocyte Growth Factor Receptor Expression in Patients with Perihilar Cholangiocarcinoma
    Hiroyuki Watanabe
    Yukihiro Yokoyama
    Toshio Kokuryo
    Tomoki Ebata
    Tsuyoshi Igami
    Gen Sugawara
    Takashi Mizuno
    Yoshie Shimoyama
    Masato Nagino
    Annals of Surgical Oncology, 2015, 22 : 2235 - 2242
  • [25] Hepatocyte growth factor and hepatocyte growth factor receptor in the lacrimal gland, tears, and cornea
    Li, Q
    Weng, J
    Mohan, RR
    Bennett, GL
    Schwall, R
    Wang, ZF
    Tabor, K
    Kim, J
    Hargrave, S
    Cuevas, KH
    Wilson, SE
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (05) : 727 - 739
  • [26] EXPRESSION OF HEPATOCYTE GROWTH-FACTOR AND OF ITS RECEPTOR IN RAT LUNG
    KATYAL, SL
    OGASAWARA, H
    MASUHARA, M
    NAKAMURA, T
    SINGH, G
    HOOK, G
    SHINOZUKA, H
    FASEB JOURNAL, 1992, 6 (04): : A1162 - A1162
  • [27] Hepatocyte growth factor and its receptor Met are induced in crescentic glomerulonephritis
    Rampino, T
    Gregorini, M
    Camussi, G
    Conaldi, PG
    Soccio, G
    Maggio, M
    Bottelli, A
    Dal Canton, A
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (06) : 1066 - 1074
  • [28] HEPATOCYTE GROWTH-FACTOR AND ITS RECEPTOR - ROLE IN TUMOR PROGRESSION
    COMOGLIO, PM
    ANNALES DE BIOLOGIE CLINIQUE, 1993, 51 (3-5) : 246 - 247
  • [29] Hepatocyte growth factor for tissue organization and its potential therapeutic application
    Matsumoto, K
    Nakamura, T
    TISSUE ENGINEERING FOR THERAPEUTIC USE 2, 1998, 1170 : 73 - 83
  • [30] The hepatocyte growth factor receptor, Met, in prostate cancer invasion and metastasis
    Knudsen, BS
    You, X
    Gmyrek, G
    Vaughan, ED
    Vande Woude, G
    MODERN PATHOLOGY, 2002, 15 (01) : 167A - 168A
12345